Eyebright Medical Technology Beijing Co Ltd (688050) — Cash Flow-to-Debt Ratio
Eyebright Medical Technology Beijing Co Ltd (688050) has a Cash Flow-to-Debt Ratio of 0.09x as of September 2025, meaning its operating cash flow of CN¥76.92 Million could theoretically repay 0% of its total liabilities (CN¥894.96 Million) in one year. Check total reinvestment intensity of Eyebright Medical Technology Beijing Co to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Eyebright Medical Technology Beijing Co Ltd Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Eyebright Medical Technology Beijing Co Ltd across 10 annual periods. Also explore Eyebright Medical Technology Beijing Co (688050) total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Eyebright Medical Technology Beijing Co Ltd (2016–2025)
Year-by-year debt coverage analysis for Eyebright Medical Technology Beijing Co Ltd. For market capitalisation and broader financial context, see Eyebright Medical Technology Beijing Co market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.40x | CN¥369.15 Million | CN¥917.65 Million | ▼ -0.2% |
| 2024 | 0.40x | CN¥347.75 Million | CN¥862.71 Million | ▲ +25.7% |
| 2023 | 0.32x | CN¥226.27 Million | CN¥705.85 Million | ▼ -58.4% |
| 2022 | 0.77x | CN¥250.13 Million | CN¥324.30 Million | ▲ +8.1% |
| 2021 | 0.71x | CN¥219.30 Million | CN¥307.46 Million | ▼ -47.4% |
| 2020 | 1.36x | CN¥123.35 Million | CN¥90.89 Million | ▲ +2.8% |
| 2019 | 1.32x | CN¥50.49 Million | CN¥38.26 Million | ▲ +35.2% |
| 2018 | 0.98x | CN¥31.82 Million | CN¥32.59 Million | ▲ +1726.2% |
| 2017 | 0.05x | CN¥4.15 Million | CN¥77.62 Million | ▲ +172.8% |
| 2016 | -0.07x | CN¥-3.37 Million | CN¥45.88 Million | — |